ICH gives CGT developers a regulatory framework that finally matches the speed and flexibility their groundbreaking therapies ...

HPAPI manufacturing requires the highest safety and containment standards. With geopolitical tensions threatening critical ...

Nearly two dozen antibody drug conjugates (ADCs) have now been approved worldwide and revenues were already well into the ...

The latest in a trend of companies stepping back from cell and gene therapies amid regulatory uncertainty and manufacturing ...

The results strengthen Jiangsu Hengrui’s dominance in the Chinese HCC market, showing potential for camrelizumab and ...

Ventus has entered a multi-year partnership with Roche’s Genentech for the discovery and optimisation of new small-molecule ...

Health Canada has granted conditional approval for Gilead Sciences’ Lyvdelzi for PBC patients who have difficulty with ...

Merck KGaA could now have a head start in the race to market Precem-TcT, which could become the first widely approved ADC in ...

Gibson, Dunn & Crutcher and White & Case have emerged as the foremost legal advisers for mergers and acquisitions (M&A) in ...

Novo Nordisk will hold a meeting to elect new board members following a disagreement between the board and its majority shareholder.

Morgan Stanley has secured the leading position as a financial adviser by deal value in South & Central America's M&A sector.

JP Morgan and Rothschild & Co have emerged as the top mergers and acquisitions (M&A) financial advisers in the Middle East & ...